New York, NY, United States of America

Urnani Reiss

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Urnani Reiss. Retrieved from https://idiyas.com/inventor/urnani-reiss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Urnani Reiss: Innovator in Cardiovascular Treatment

Introduction

Urnani Reiss is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cardiovascular medicine through his innovative research and patent.

Latest Patents

Urnani Reiss holds a patent for "Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs." This patent outlines methods for the prevention and treatment of cardiovascular diseases. The methods involve administering an effective amount of a non-steroidal anti-inflammatory drug, either alone or in combination with other therapies, to induce apoptosis, reduce proliferation, induce quiescence, inhibit cell migration, or influence cell differentiation of the cells in the vascular wall and/or induce hypolipidemia.

Career Highlights

Throughout his career, Urnani Reiss has focused on advancing medical treatments for cardiovascular conditions. His work has been instrumental in developing new therapeutic approaches that leverage non-steroidal anti-inflammatory drugs.

Collaborations

Urnani has collaborated with esteemed colleagues, including Edward A Fisher and Steven Shiff, to further enhance the impact of his research in the medical community.

Conclusion

Urnani Reiss is a dedicated inventor whose work in cardiovascular treatment has the potential to improve patient outcomes significantly. His innovative approaches and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…